GEHC GE HealthCare

Q3 2025 10-Q

Filed: Oct 29, 2025Period ending Sep 30, 2025

Health Care

X-Ray Apparatus & Tubes & Related Irradiation ApparatusSEC EDGAR

GE HealthCare (GEHC) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 29, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Quarterly revenue $5,143M, up 6% YoY from $4,863M; nine-month revenue $14,927M, up 4% YoY from $14,353M
• Operating margin 12.7% vs 13.9% YoY Q3; nine-month operating margin 13.0% vs 12.7% YoY, net income margin 10.0% vs 8.9% YoY

+3 more insights

Risk Factors

• No material changes to risk factors from fiscal 2024 10-K disclosed this quarter

Quarterly Financial Summary
XBRL

Revenue

$5.1B

▲ +5.7% YoY▲ +2.7% QoQ

Net Income

$446M

▼ -5.1% YoY▼ -8.0% QoQ

Gross Margin

38.7%

▼ -296bp YoY▼ -95bp QoQ

Operating Margin

12.7%

▼ -120bp YoY▼ -36bp QoQ

Net Margin

8.7%

▼ -99bp YoY▼ -101bp QoQ

ROE

4.5%

Total Assets

$36.1B

EPS (Diluted)

$0.97

▼ -4.9% YoY▼ -8.5% QoQ

Operating Cash Flow

$593M

▼ -20.1% YoY▲ +530.9% QoQ

Source: XBRL data from GE HealthCare Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on GE HealthCare

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.